retatrutide lancet Shows Metabolic Benefits in Phase 3 Studies What Is Retatrutide? How Does

Making an Informed Decision About Dosing The relationship between dose, efficacy, and tolerability creates important choices for users

As oral but not intraperitoneal glucose administration stimulates the parasympathetic aspects of the gut-brain axis to centrally mediate hepatic glucose production (168), these findings suggest that INSL-5 may influence glucose homeostasis via direct actions on hepatocytes to influence hepatic gluconeogenesis

Medicaid plans cover drugs for Type 2 diabetes, like Ozempic, but prescription coverage with Medicaid varies by state

Eli Lilly announced positive topline Phase 3 results in March 2026 for a type 2 diabetes study, and multiple Phase 3 trials remain active across obesity and related conditions